Figure 2. Research funding sources used by the inquired research groups participating at OneHealth drugs for drug development against PVBD.

To put research projects in practice, the great majority of the research groups working on drug development for the treatment of PVBDs rely on government funds for research (69%), Academia (57%) and private funding (28%). Only 25% had received funding from the European Commission.